Unicycive Therapeutics, Inc.UNCYNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-5.44%
↑ 80% above average
Average (26q)
-27.11%
Historical baseline
Range
High:51.21%
Low:-505.26%
Volatility
-2052.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -5.44% |
| Q2 2025 | 12.84% |
| Q1 2025 | 13.74% |
| Q4 2024 | -48.15% |
| Q3 2024 | 15.54% |
| Q2 2024 | 19.59% |
| Q1 2024 | -45.79% |
| Q4 2023 | -6.32% |
| Q3 2023 | -37.39% |
| Q2 2023 | -2.86% |
| Q1 2023 | 21.09% |
| Q4 2022 | 4.12% |
| Q3 2022 | -52.75% |
| Q2 2022 | -2.80% |
| Q1 2022 | -28.52% |
| Q4 2021 | 41.63% |
| Q3 2021 | -505.26% |
| Q2 2021 | -6.57% |
| Q1 2021 | -1.95% |
| Q4 2020 | -14.54% |
| Q3 2020 | -86.31% |
| Q2 2020 | 1.75% |
| Q1 2020 | 51.21% |
| Q4 2019 | -45.74% |
| Q3 2019 | -23.18% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |